Goodwin Procter LLP advised Biond Biologics on the deal. Biond Biologics Ltd. announced its exclusive worldwide license agreement with Sanofi (EURONEXT: SAN) (NASDAQ: SNY), for the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
